Literature DB >> 11491008

Resistance of Plasmodium falciparum to antimalarial drugs in a highly endemic area of southern Viet Nam: a study in vivo and in vitro.

N M Huong1, S Hewitt, T M Davis, L D Dao, T Q Toan, T B Kim, N T Hanh, V N Phuong, D H Nhan, L D Cong.   

Abstract

To assess the antimalarial sensitivity of Plasmodium falciparum in vivo and in vitro in a highly endemic area of southern Viet Nam, a field study was conducted (in 1999) at a rubber plantation in Binh Phuoc Province north of Ho Chi Minh City. Fifty patients were treated with either artesunate (4 mg/kg on day 0, then 2 mg/kg on day 1 to 4) or mefloquine (10 mg/kg at 0 h, then 5 mg/kg at 6 h), and their progress was followed for 28 days under standard WHO protocols. Blood spots were taken at baseline from all patients, as well as from those who redeveloped parasitaemia during follow-up, for polymerase chain reaction (PCR) determination of parasite genotypes to assist differentiation of re-infection from recrudescence. Both treatments cleared parasites within 5 days. Of the 25 mefloquine-treated patients, 2 (8%) re-presented with probable re-infections. For artesunate, 4 patients (16%) had re-infections and 5 (20%) had recrudescences. Sensitivity tests in vitro of pre-treatment P. falciparum isolates showed geometric mean IC50 values of 29, 38, 209 and 15 nmol/L for chloroquine (n = 32), mefloquine (n = 33), quinine (n = 31) and artemisinin (n = 31), respectively. There were significant correlations between IC50s for artemisinin and mefloquine (r = 0.72, P = 0.004), and chloroquine and quinine (r = 0.44, P = 0.05). These data show that, although mefloquine has been used for 10 years in Binh Phuoc Province, it remains fully effective, perhaps because an artemisinin derivative is commonly given at the same time. The recrudescence rate for artesunate is similar to those reported in other epidemiological contexts. The present in-vitro data imply that quinine remains effective and that reduced drug pressure has been associated with increased sensitivity of local strains of P. falciparum to chloroquine. Although from one hyperendemic area, these results may have implications for antimalarial prophylaxis and treatment strategies for residents and travellers to southern Viet Nam.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11491008     DOI: 10.1016/s0035-9203(01)90254-8

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  15 in total

1.  In vitro antimalarial drug susceptibility and pfcrt mutation among fresh Plasmodium falciparum isolates from the Lao PDR (Laos).

Authors:  Mayfong Mayxay; Marion Barends; Alan Brockman; Anchalee Jaidee; Shalini Nair; Dan Sudimack; Tiengkham Pongvongsa; Samlane Phompida; Rattanaxay Phetsouvanh; Tim Anderson; Nicholas J White; Paul N Newton
Journal:  Am J Trop Med Hyg       Date:  2007-02       Impact factor: 2.345

2.  Monitoring Plasmodium falciparum chloroquine resistance in Yunnan Province, China, 1981-2006.

Authors:  Henglin Yang; Yaming Yang; Pinfang Yang; Xingliang Li; Baihe Gao; Zhiyong Zhang; Zhaoqing Yang; Liwang Cui
Journal:  Acta Trop       Date:  2008-09-06       Impact factor: 3.112

3.  Update on the efficacy, effectiveness and safety of artemether-lumefantrine combination therapy for treatment of uncomplicated malaria.

Authors:  Pauline Byakika-Kibwika; Mohammed Lamorde; Harriet Mayanja-Kizza; Concepta Merry; Bob Colebunders; Jean-Pierre Van Geertruyden
Journal:  Ther Clin Risk Manag       Date:  2010-02-02       Impact factor: 2.423

4.  In vitro activity and interaction of clindamycin combined with dihydroartemisinin against Plasmodium falciparum.

Authors:  M Ramharter; H Noedl; H Winkler; W Graninger; W H Wernsdorfer; P G Kremsner; S Winkler
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

5.  Resistance to antimalarials in Southeast Asia and genetic polymorphisms in pfmdr1.

Authors:  Amy L Pickard; Chansuda Wongsrichanalai; Anne Purfield; Deborah Kamwendo; Kathryn Emery; Christy Zalewski; Fumihiko Kawamoto; R Scott Miller; Steven R Meshnick
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

6.  Artemisinin resistance in Plasmodium falciparum is associated with an altered temporal pattern of transcription.

Authors:  Sachel Mok; Mallika Imwong; Margaret J Mackinnon; Joan Sim; Ramya Ramadoss; Poravuth Yi; Mayfong Mayxay; Kesinee Chotivanich; Kek-Yee Liong; Bruce Russell; Duong Socheat; Paul N Newton; Nicholas P J Day; Nicholas J White; Peter R Preiser; François Nosten; Arjen M Dondorp; Zbynek Bozdech
Journal:  BMC Genomics       Date:  2011-08-03       Impact factor: 3.969

7.  Resistance of a rodent malaria parasite to a thymidylate synthase inhibitor induces an apoptotic parasite death and imposes a huge cost of fitness.

Authors:  Francis W Muregi; Isao Ohta; Uchijima Masato; Hideto Kino; Akira Ishih
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240

8.  A database of antimalarial drug resistance.

Authors:  Carol Hopkins Sibley; Pascal Ringwald
Journal:  Malar J       Date:  2006-06-15       Impact factor: 2.979

9.  Delayed Plasmodium falciparum clearance following artesunate-mefloquine combination therapy in Thailand, 1997-2007.

Authors:  Saowanit Vijaykadga; Alisa P Alker; Wichai Satimai; John R MacArthur; Steven R Meshnick; Chansuda Wongsrichanalai
Journal:  Malar J       Date:  2012-08-28       Impact factor: 2.979

10.  In vitro antimalarial drug susceptibility in Thai border areas from 1998-2003.

Authors:  Wanna Chaijaroenkul; Kesara Na Bangchang; Mathirut Mungthin; Stephen A Ward
Journal:  Malar J       Date:  2005-08-02       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.